Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes

Cardiovascular Research

Volumn 37, Issue 3, 1998, Pages 700-709

  Miura, Tetsuji ^a   Miura, Toshiro ^b   Kawamura, Shuji ^b   Goto, Mahiko ^a   Sakamoto, Jun ^a   Tsuchida, Akihito ^a   Matsuzaki, Masunori ^b   Shimamoto, Kazuaki ^a  

^a SAPPORO MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Adenosine receptor; Myocardial infarction; Protein kinase C; Rabbit

Indexed keywords

8 (4 SULFOPHENYL)THEOPHYLLINE; ADENOSINE RECEPTOR BLOCKING AGENT; POLYMYXIN B; STAUROSPORINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONDITIONING; CONTROLLED STUDY; ENZYME INHIBITION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; RABBIT;

ANIMALS; CELL MEMBRANE; CYTOSOL; ENZYME INHIBITORS; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIUM; POLYMYXIN B; PROTEIN KINASE C; RABBITS; RANDOM ALLOCATION; RECEPTORS, PURINERGIC P1; STAUROSPORINE; THEOPHYLLINE;

EID: 17744401410     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(97)00244-7     Document Type: Article

References (39)

1. [1] Murry CE, Jennings RB, Reimer KA. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986;74:1124-1136.
2. [2] J.M Downey, T Miura, The role of adenosine in ischemic preconditioning. In: M Hori, Y Maruyama, R.S Reneman, eds. Cardiac Adaptation and Failure, Tokyo: Springer Verlag, (1994) 147-166.
3. [3] Wall TM, Sheely R, Harmtman JC. Role of bradykinin in myocardial preconditioning. J Pharmacol Exp Ther 1994;270:681-689.
4. [4] Goto M, Liu Y, Yang XM, Ardell JL, Cohen MV, Downey JM. Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ Res 1995;77:611-621.
5. [5] Chien GL, Tang Y, Van Winkle DM. Stereospecific blockade of myocardial ischemic preconditioning by naloxone. Circulation 1995;92(Suppl I):I-389. Abstract.
6. [6] Ytrehus K, Liu Y, Downey JM. Preconditioning protects ischemic rabbit heart by protein kinase C activation. Am J Physiol 1994;266:H1145-H1152.
7. [7] Speechly-Dick ME, Mocanu MM, Yellon DM. Protein kinase C. Its role in ischemic preconditioning in the rat. Circ Res 1994;75:586-590.
8. [8] Kitakaze M, Node K, Minamino T, et al. Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′-nucleotidase. Circulation 1996;93:781-791.
9. [9] Liu Y, Cohen MV, Downey JM. Chelerythrine, a highly selective protein kinase C inhibitor, blocks the anti-infarct effect of ischemic preconditioning in rabbit hearts. Cardiovasc Drugs Ther 1994;8:881-882.
10. [10] Liu Y, Kloner RA. Does protein kinase C play a role in ischemic preconditioning in rat hearts?. Am J Physiol 1995;268:H426-H431.
11. [11] Przyklenk K, Sussman MA, Simkhovich BZ, Kloner RA. Does ischemic preconditioning trigger translocation of protein kinase C in the canine model?. Circulation 1995;92:1546-1557.
12. [12] Vogt A, Barancik M, Weihrauch D, Arras M, Podzuweit T, Schaper W. Protein kinase C inhibitors reduce infarct size in pig hearts in vivo. Circulation 1994;90:I-647. Abstract.
13. [13] Vahlhause C, Schultz R, Post H, Onallah R, Heusch G. No prevention of ischemic preconditioning by the protein kinase C inhibitor staurosporine in swine. Circ Res 1996;79:407-414.
14. [14] Armstrong SC, Hoover DB, Delacey MH, Ganote CE. Translocation of PKC, protein phosphatase inhibition and preconditioning of rabbit cardiomyocytes. J Mol Cell Cardiol 1996;28:1479-1492.
15. [15] Simkhovich BZ, Przyklenk K, Hale SL, Patterson M, Kloner RA. Direct evidence that ischemic preconditioning does not cause protein kinase C translocation in rabbit heart. Cardiovasc Res 1996;32:1064-1070.
16. [16] Miura T, Goto M, Urabe K, Endoh A, Shimamoto K, Iimura O. Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning?. Circulation 1991;84:2504-2512.
17. [17] Iwamoto T, Miura T, Adachi T, et al. Myocardial infarct size-limiting effect of ischemic preconditioning was not attenuated by oxygen free-radical scavengers in the rabbit. Circulation 1991;83:1015-1022.
18. [18] Sakamoto J, Miura T, Goto M, Iimura O. Limitation of myocardial infarct size by adenosine A1 receptor activation is abolished by protein kinase C inhibitors in the rabbit. Cardiovasc Res 1995;29:682-688.
19. [19] Tsuchida A, Miura T, Miki T, Shimamoto K, Iimura O. Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning. Cardiovasc Res 1992;26:456-461.
20. [20] Tsuchida A, Liu Y, Liu GS, Cohen MV, Downey JM. Alpha 1-adrenergic agonists precondition rabbit ischemic myocardium independent of adenosine by direct activation of protein kinase. C Circ Res 1994;75:576-585.
21. [21] Nachlas MM, Schnitka TK. Macroscopic identification of early myocardial infarction by alterations in dehydrogenase activity. Am J Pathol 1963;42:379-405.
22. [22] The United States Pharmacopeia 23, Rockville: United States Phramacopeial Convention, Inc., 1995.
23. [23] Yoshida K, Hirata T, Akita Y, et al. Translocation of protein kinase C-α, δ and ε isoforms in ischemic rat heart. Biochim Biophys Acta 1996;1317:36-44.
24. [24] Miura T, Downey JM, Ooiwa H, et al. Progression of myocardial infarction in a collateral flow deficient species. Jpn Heart J 1989;30:695-708.
25. 2+-dependent protein kinase. Biochem Biophys Res Commun 1982;109:1129-1133.
26. [26] Robinson PJ, Cheng HC, Black CK, et al. MDL 27,032 [4-propyl-5-(4-pyridinyl)-2(3H)-oxazolone], an active site-directed inhibitor of protein kinase C and cyclic AMP-dependent protein kinases that relaxes vascular smooth muscle. J Pharmacol Exp Ther 1990;255:1392-1398.
27. [27] Kawamura S, Yoshida K, Miura T, Mizukami Y, Matsuzaki M. Ischemic preconditioning translocate protein kinase C isoforms to the membrane fraction. Circulation 1996;94(Suppl I):I-392. Abstract.
28. [28] Miki T, Sato H, Cohen MV, Downey JM. Opioid receptor contributes to ischemic preconditioning through protein kinase C activation in rabbits. Circulation 1996;94(Suppl I):I392-I393. Abstract.
29. [29] Van Wylen DGL. Effect of ischemic preconditioning on interstitial purine metabolite and lactate accumulation during myocardial ischemia. Circulation 1994;89:2283-2289.
30. [30] Miura T, Suzuki K, Shimamoto K, Iimura O. Suppression of the degradation of adenine nucleotides during ischemia may not be a sufficient mechanism for infarct size limitation by preconditioning. Basic Res Cardiol 1996;91:425-432.
31. [31] Li GC, Vasquez JA, Gallagher KP, Lucchesi BR. Myocardial protection with preconditioning. Circulation 1990;82:609-619.
32. [32] Liu Y, Downey JM. Ischemic preconditioning protects against infarction in rat heart. Am J Physiol 1992;263:H1107-H1112.
33. [33] Grover GJ, Dzwonczyk S, Sleph PG, Sargent CA. The ATP-sensitive potassium channel blocker glibenclamide (glyburide) does not abolish preconditioning in isolated ischemic rat hearts. J Pharmacol Exp Ther 1993;265:559-564.
34. [34] Li Y, Kloner RA. Cardioprotective effects of ischemic preconditioning are not mediated by adenosine receptors in rat hearts. Circulation 1993;87:1642-1648.
35. [35] Gross GJ, Auchampach JA. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992;70:223-233.
36. [36] Gross GJ, Mei DA, Schultz JJ, Mizumura T. Criteria for a mediator or effector of myocardial preconditioning: Do KATP channels meet the requirements?. Basic Res Cardiol 1996;91:31-34.
37. [37] Van Winkle DM, Chien GL, Wolff RA, Soifer BE, Kuzume K, Davis RF. Cardioprotection provided by adenosine receptor activation is abolished by blockade of the KATP channel. Am J Physiol 1994;266:H829-H839.
38. [38] Hagege J, Delarue F, Peraldi MN, Srarer JD, Rondeau E. Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. Lab Invest 1994;71:826-837.
39. [39] Imai T, Hirata Y, Marumo F. Heparin inhibits endothelin-1 and proto-oncogene c-fos gene expression in cultured bovine endothelial cells. J Cardiovasc Pharmacol 1993;22(Suppl.8):S49-S52.